With an increase in pharmaceutical needs, and a shift in medical treatments needed to fight and prevent COVID-19, we can expect change management from health authorities and organizations. Inevitably, this could lead to drastic price changes and insufficient drug availability on national and global levels. In this session, we´ll analyze the current situation facing pharmaceutical companies today and examine the outlook for the industry. We will also dive into pricing model trends including: outcome-based pricing, indication-based pricing, and subscription- or mortgage-based pricing models.
If you have the following questions, this session is for you:
- What are market challenges to consider?
- What pricing trends are on the horizon?
- What to do next to stay agile and successful?
Business Development Manager for Life Sciences at Vistex EMEA
Alejandra Garitonandía is the Business Development Manager for Life Sciences at Vistex EMEA. She is specialized in revenue management for Pharma and has a background in medical and business educational studies. During her international career, she holds different positions in business and IT. Her specialization is where business processes meet the IT systems and how to support efficient end-to-end revenue management.